We are live on ! Find out more
LAB icon

Standard BioTools

84 hedge funds and large institutions have $217M invested in Standard BioTools in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 8184 (+3)

5% more call options, than puts

Call options by funds: $238K | Put options by funds: $227K

0.42% more ownership

Funds ownership: 95.01%95.42% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $217M → $217M (-$852K)

Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
38
Reduced
18
Closed
9
Calls
$238K
Puts
$227K
Net Calls
+$11K
Net Calls Change
+$28K
Name Holding Trade Value Shares
Change
Change in
Stake
TI
51
Trexquant Investment
Connecticut
$165K +$185K +28,233 New
State Board of Administration of Florida Retirement System
52
State Board of Administration of Florida Retirement System
Florida
$160K
Balyasny Asset Management
53
Balyasny Asset Management
Illinois
$149K +$94.5K +14,388 +130%
AIG
54
American International Group
New York
$145K -$8.75K -1,332 -5%
EGM
55
Engineers Gate Manager
New York
$128K +$143K +21,850 New
SEI Investments
56
SEI Investments
Pennsylvania
$127K +$13.9K +2,121 +11%
MIM
57
MetLife Investment Management
New Jersey
$120K
SAM
58
Silverback Asset Management
North Carolina
$116K -$953K -145,102 -88%
Adage Capital Partners
59
Adage Capital Partners
Massachusetts
$109K -$7.65M -1,165,407 -98%
PP
60
Paloma Partners
Connecticut
$99K
TRCT
61
Tower Research Capital (TRC)
New York
$99K +$46.8K +7,133 +73%
VOYA Investment Management
62
VOYA Investment Management
Georgia
$93K
SAM
63
Silphium Asset Management
United Kingdom
$92.6K +$104K +15,848 New
CS
64
Credit Suisse
Switzerland
$89K +$15.1K +2,292 +18%
MLICM
65
Metropolitan Life Insurance Company (MetLife)
New York
$81.6K +$34.8K +5,296 +61%
DTL
66
Dynamic Technology Lab
Singapore
$80K +$89.4K +13,618 New
SIM
67
Spark Investment Management
New York
$73K +$6.57K +1,000 +9%
Barclays
68
Barclays
United Kingdom
$63K +$31.3K +4,763 +77%
TPWA
69
TRUE Private Wealth Advisors
Oregon
$58K +$65.7K +10,000 New
Simplex Trading
70
Simplex Trading
Illinois
$54K +$61.6K +9,382 New
BNP Paribas Financial Markets
71
BNP Paribas Financial Markets
France
$52.7K +$1.6K +243 +3%
JP Morgan Chase
72
JP Morgan Chase
New York
$51K -$386K -58,744 -87%
Legal & General Group
73
Legal & General Group
United Kingdom
$40K -$18K -2,742 -29%
PCM
74
Prelude Capital Management
New York
$28K +$12.7K +1,939 +70%
Bank of America
75
Bank of America
North Carolina
$17K -$9.96K -1,517 -33%

LAB Hedge Fund Activity: Q1 2018 in Review

84 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2018, worth a combined $217M — down 0.39% from $217M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LAB positions and 9 closed out — a net gain of 3 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $3.6M. The largest seller was Adage Capital Partners, cutting an estimated $7.65M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q1 2018, up from 81 in Q4 2017.
  • Funds reported $217M of Standard BioTools stock for Q1 2018, down 0.39% quarter-over-quarter.
  • 12 funds opened new Standard BioTools positions in Q1 2018 and 9 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q1 2018 was Levin Capital Strategies, an estimated $3.6M added.
  • The largest Standard BioTools seller in Q1 2018 was Adage Capital Partners, an estimated $7.65M sold.

Based on aggregated 13F filings for Q1 2018.